Kairos Pharma, LTD.
Kairos Pharma, LTD. (KAPA): 7 pipeline candidates · ~11 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
11.3 months
0% dilution
Lead: Phase 2
7 candidates
N/A
N/A
A transparent, data-derived signal for Kairos Pharma, LTD.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$9.4M
Cash
$3.7M
Quarterly Burn
$1.0M
Runway
11.3 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$402K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 463,756 | $259K |
| geode capital management, llc | 111,290 | $62K |
| vanguard fiduciary trust co | 63,884 | $36K |
| two sigma investments, lp | 39,543 | $22K |
| state street corp | 24,100 | $13K |
| two sigma securities, llc | 16,247 | $9K |
| hrt financial lp | 21,575 | $12 |
| citigroup inc | 10 | $6 |
Frequently asked questions
How many drug candidates are in Kairos Pharma, LTD.'s pipeline?
Kairos Pharma, LTD. (KAPA) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Kairos Pharma, LTD.'s lead drug candidate?
Kairos Pharma, LTD.'s most advanced tracked candidate is env 105 (Phase 2) for prostate cancer and non-small cell lung cancer.
What is Kairos Pharma, LTD.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Kairos Pharma, LTD. has approximately 11.3 months of cash runway.
What is Kairos Pharma, LTD.'s market capitalization?
Kairos Pharma, LTD.'s market capitalization is approximately $9.4M.
Who is the CEO of Kairos Pharma, LTD.?
Dr. John S. Yu M.D., Ph.D. is the chief executive officer of Kairos Pharma, LTD. (KAPA).
Get the full picture on Kairos Pharma, LTD.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.